Separate indirect from direct design evidence (SIDDE)

Fixed effects model: 

               comparison k  nma direct indir. RoR z p-value
 daridorexant:eszopiclone 0 0.63      .   0.63   . .       .
 daridorexant:lemborexant 0 0.44      .   0.44   . .       .
   daridorexant:melatonin 0 2.31      .   2.31   . .       .
     daridorexant:placebo 1 0.99   0.99      .   . .       .
  eszopiclone:lemborexant 0 0.70      .   0.70   . .       .
    eszopiclone:melatonin 0 3.64      .   3.64   . .       .
      eszopiclone:placebo 2 1.56   1.56      .   . .       .
    lemborexant:melatonin 0 5.21      .   5.21   . .       .
      lemborexant:placebo 2 2.24   2.24      .   . .       .
        melatonin:placebo 1 0.43   0.43      .   . .       .

Legend:
 comparison - Treatment comparison
 k          - Number of studies providing direct evidence
 nma        - Estimated treatment effect (OR) in network meta-analysis
 direct     - Estimated treatment effect (OR) derived from direct evidence
 indir.     - Estimated treatment effect (OR) derived from indirect evidence
 RoR        - Ratio of Ratios (direct versus indirect)
 z          - z-value of test for disagreement (direct versus indirect)
 p-value    - p-value of test for disagreement (direct versus indirect)
[1] "Percent of comparisons where there is some evidence (p-value<0.05) of disagreement between direct and indirect sources: NaN. (0 out of 0 comparisons)."
[1] "File created on 2022-06-09"
